Pharmaceutical Stocks

Pharmaceutical stocks have grown tremendously as medicine advances. With diseases like diabetes and even Ebola affecting more and more of the population, pharmaceutical companies are racing to find cures – further  advancing medicine and driving their stock prices up. Corporations like Pfizer (NYSE:PFE) and Gilead Sciences (NASDAQ:GILD) are leading the charge against disease but smaller companies such as Myland (NASDAQ:MYL) are interesting investments as well.

Recent Articles

Why My Favorite Pick In Pharma Today is Eli Lilly and Co (LLY)

Big pharma has some great long-term drivers, and a wealth of these help power my favorite pharma pick, Eli Lilly. Look to LLY for value More 

3 Troubled Pharma Stocks That Could Rally Soon

Pharma stocks have been hit hard by scandals, public outcries and industry-related setbacks, but there's still hope for a recovery. More 

Valeant Pharmaceuticals Intl Inc’s Hard Times Mean Avoid VRX Stock

Investors and analysts are raising their eyebrows over some strange goings on at Valeant Pharmaceuticals, leading to our bear call on VRX stock More 

Bear of the Day: AbbVie Inc Slide Shows No Quick End (ABBV)

AbbVie Inc is under pressure as the government reviews a patent and competitor Coherus waits in the wings More 

Is Pfizer Inc. Finally Safe To Buy Again? (PFE)

A first-quarter earnings and revenue beat has investors excited once again with formerly beat-down Pfizer Inc. Is now the time to buy PFE? More 

2 Drug Stocks To Buy For Safe Dividends And 20% Gains

With all the talk on the campaign trail about drug costs, it's safe to say the pharmaceutical industry is under siege. But these drug stocks are solid buys More 

Johnson & Johnson: How Healthy Is JNJ Stock?

Johnson & Johnson (JNJ) stock has long been a mainstay of many investors' healthcare holdings. But is JNJ's future still bright? More 

Pfizer Inc. Stock: A Good Buy While the Pharma Industry Is Down (PFE)

Between a planned merger with Allergan and a strong pipeline of drugs, PFE stock is a solid choice at a great price. More 

Bull of the Day: Momentum Powers Celgene Stock

Celgene's analyst conference was deceiving, as its estimated disappointed. But CELG stock is a pharmaceutical buy on it's forward momentum More 

Broker Darling: Pfizer Ranks As a Top 15 Analyst Pick (PFE)

A study of analyst recommendations shows that Pfizer is the #5 broker pick, on average, out of the 30 stocks making up the Dow Jones. More